Q3 2026 Earnings Call March 4, 2026 7:00 PM ESTCompany ParticipantsEric Schmiedchen - Head of Investor RelationsAlfred Felder ...
Altimmune, Inc. (NASDAQ:ALT) Q4 2025 Earnings Call Transcript March 5, 2026 Altimmune, Inc. misses on earnings expectations. Reported EPS is $-0.27191 EPS, expectations were $-0.25. Operator: Good ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results